NOVO HOLDINGS A/S sold 2.8% of their position (101.90K shares) of CYTEIR THERAPEUTICS, INC. on the open market
Open‑market sale worth $280.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/20/2023ACC: 0001209191-23-042977
10% Owner
Since Jun 2021
-101.90K
Net shares
Net seller
$280.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
101.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.90K
Price / share
$2.76
Trade value
$5.25K
% of position
0.1%
7/19/2023
3.62M→3.62M
Common Stock
Direct
Shares
−100K
Price / share
$2.75
Trade value
$275.14K
% of position
2.8%
7/20/2023
3.62M→3.52M
Total
Net shares
−101.90K
Net value
-$280.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/19/2023 | S · Sale | −1.90K | $2.76 | $5.25K | 0.1% | 3.62M | 3.62M |
| Common Stock Direct | 7/20/2023 | S · Sale | −100K | $2.75 | $275.14K | 2.8% | 3.62M | 3.52M |
| Total | −101.90K | -$280.39K | ||||||
Derivative Transactions0
No derivative transactions reported